Agniwo, Privat http://orcid.org/0000-0002-6913-490X
Sidibé, Bakary
Diakité, Assitan
Niaré, Safiatou Doumbo
Guindo, Hassim
Akplogan, Ahristode
Ibikounlé, Moudachirou
Boissier, Jérôme
Dabo, Abdoulaye
Article History
Received: 8 November 2022
Accepted: 21 February 2023
First Online: 20 April 2023
Declarations
:
: The proposal was reviewed and approved by the Institutional Review Board (IRB) of the Faculty of Medicine, Pharmacy and Dentistry, University of Bamako under the number 2018/71/CE/FMPOS. Community consent was obtained before starting the study. The parent or guardian of each study participant signed a consent form. At the end of the study, all of the positive children were treated with PZQ (40 mg/kg body weight) according to the Schistosomiasis and STH National Control Program strategy in Mali (PNLSH).
: Not applicable.
: The authors declare that they have no competing interests.